Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Walt Disney
DIS
|
+$137M |
| 2 |
Alibaba
BABA
|
+$107M |
| 3 |
Microsoft
MSFT
|
+$78.7M |
| 4 |
Amazon
AMZN
|
+$70.3M |
| 5 |
Fox Class A
FOXA
|
+$44M |
Top Sells
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$165M |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$68.3M |
| 3 |
Oracle
ORCL
|
+$45.5M |
| 4 |
PG&E
PCG
|
+$41.2M |
| 5 |
Qualcomm
QCOM
|
+$30M |
Sector Composition
| 1 | Technology | 19.66% |
| 2 | Healthcare | 15.18% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Communication Services | 10.1% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUD
1976
DELISTED
Audacy, Inc.
AUD
| $1.19M | ﹤0.01% |
227,144
+3,800
| +2% | +$20K |
|
1977
Regis Corp
RGS
$70.8M
| $1.19M | ﹤0.01% |
3,030
+95
| +3% | +$37.4K |
|
1978
Preferred Bank
PFBC
$1.16B
| $1.19M | ﹤0.01% |
26,489
+700
| +3% | +$31.5K |
|
1979
Adtran
ADTN
$809M
| $1.19M | ﹤0.01% |
86,800
+3,500
| +4% | +$47.9K |
|
1980
UroGen Pharma
URGN
$869M
| $1.19M | ﹤0.01% |
32,200
+14,000
| +77% | +$517K |
|
1981
Camden National
CAC
$684M
| $1.18M | ﹤0.01% |
28,361
+800
| +3% | +$33.4K |
|
1982
DXP Enterprises
DXPE
$1.85B
| $1.18M | ﹤0.01% |
30,400
+1,600
| +6% | +$62.3K |
|
|
TRTX
1983
TPG RE Finance Trust
TRTX
$742M
| $1.18M | ﹤0.01% |
60,200
+2,800
| +5% | +$54.9K |
|
|
DRNA
1984
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.17M | ﹤0.01% |
80,000
+4,500
| +6% | +$65.9K |
|
1985
Axcelis
ACLS
$2.69B
| $1.17M | ﹤0.01% |
58,200
| – | – |
|
|
HT
1986
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.17M | ﹤0.01% |
68,275
+2,400
| +4% | +$41.1K |
|
1987
Photronics
PLAB
$1.33B
| $1.17M | ﹤0.01% |
123,700
| – | – |
|
1988
Viking Therapeutics
VKTX
$2.79B
| $1.17M | ﹤0.01% |
117,200
+5,600
| +5% | +$55.7K |
|
|
RDUS
1989
DELISTED
Radius Recycling
RDUS
| $1.16M | ﹤0.01% |
48,300
+1,500
| +3% | +$36K |
|
1990
Stellar Bancorp
STEL
$1.61B
| $1.16M | ﹤0.01% |
35,558
+1,100
| +3% | +$35.7K |
|
1991
Select Water Solutions
WTTR
$946M
| $1.15M | ﹤0.01% |
95,500
+4,300
| +5% | +$51.7K |
|
|
DERM
1992
DELISTED
Dermira, Inc.
DERM
| $1.15M | ﹤0.01% |
84,700
+29,000
| +52% | +$393K |
|
1993
ATN International
ATNI
$238M
| $1.15M | ﹤0.01% |
20,300
+600
| +3% | +$33.8K |
|
1994
ANI Pharmaceuticals
ANIP
$2.12B
| $1.14M | ﹤0.01% |
16,200
+500
| +3% | +$35.3K |
|
|
NWLI
1995
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.14M | ﹤0.01% |
4,349
+100
| +2% | +$26.2K |
|
1996
BioCryst Pharmaceuticals
BCRX
$1.66B
| $1.14M | ﹤0.01% |
139,900
+4,500
| +3% | +$36.6K |
|
1997
Akebia Therapeutics
AKBA
$782M
| $1.14M | ﹤0.01% |
138,585
-5,900
| -4% | -$48.3K |
|
1998
StoneX
SNEX
$5.04B
| $1.13M | ﹤0.01% |
65,700
+1,800
| +3% | +$31K |
|
1999
Northfield Bancorp
NFBK
$492M
| $1.13M | ﹤0.01% |
81,200
+2,400
| +3% | +$33.4K |
|
2000
Gorman-Rupp
GRC
$1.13B
| $1.13M | ﹤0.01% |
33,247
+900
| +3% | +$30.5K |
|